Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2398 Views
-
Last post by NHE
-
- 6 Replies
- 6895 Views
-
Last post by ElliotB
-
- 0 Replies
- 1398 Views
-
Last post by NHE
-
- 0 Replies
- 3559 Views
-
Last post by NHE
-
- 1 Replies
- 1073 Views
-
Last post by NHE
-
- 1 Replies
- 1581 Views
-
Last post by NHE
-
- 11 Replies
- 3454 Views
-
Last post by NHE
-
- 0 Replies
- 3278 Views
-
Last post by NHE
-
- 0 Replies
- 1514 Views
-
Last post by NHE